BRPI0519606A2 - sÍntese, produÇço e utilidade da taurina como um remÉdio - Google Patents

sÍntese, produÇço e utilidade da taurina como um remÉdio

Info

Publication number
BRPI0519606A2
BRPI0519606A2 BRPI0519606-0A BRPI0519606A BRPI0519606A2 BR PI0519606 A2 BRPI0519606 A2 BR PI0519606A2 BR PI0519606 A BRPI0519606 A BR PI0519606A BR PI0519606 A2 BRPI0519606 A2 BR PI0519606A2
Authority
BR
Brazil
Prior art keywords
taurine
remedy
production
synthesis
utility
Prior art date
Application number
BRPI0519606-0A
Other languages
English (en)
Inventor
Abdalla Magd Ahmed Kotb
Original Assignee
Abdalla Magd Ahmed Kotb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abdalla Magd Ahmed Kotb filed Critical Abdalla Magd Ahmed Kotb
Publication of BRPI0519606A2 publication Critical patent/BRPI0519606A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SÍNTESE, PRODUÇçO E UTILIDADE DA TAURINA COMO UM REMÉDIO. A via quantitativamente mais importante para a excreção de colesterol em mamíferos é a formação de sais biliares (as bases conjugadas de ácidos biliares) . Os principais sais biliares são sintetizados e secretados como conjugados de glicina ou taurina. A taurina (ácido 2- aminoetil sulfônico) é produzida naturalmente pelas células do fígado e pelas células do sistema nervoso central, ela é neuroprotetora e é um agente de diminuição de colesterol, virtualmente sem efeitos colaterais registrados.
BRPI0519606-0A 2005-01-05 2005-12-31 sÍntese, produÇço e utilidade da taurina como um remÉdio BRPI0519606A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EG2005010013 2005-01-05
PCT/EG2005/000044 WO2006072259A2 (en) 2005-01-05 2005-12-31 Taurine synthesis, production and utility as a medicine

Publications (1)

Publication Number Publication Date
BRPI0519606A2 true BRPI0519606A2 (pt) 2009-02-25

Family

ID=36647837

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519606-0A BRPI0519606A2 (pt) 2005-01-05 2005-12-31 sÍntese, produÇço e utilidade da taurina como um remÉdio

Country Status (15)

Country Link
EP (1) EP1844006A2 (pt)
JP (1) JP2008526789A (pt)
KR (1) KR20070091198A (pt)
CN (1) CN101146767A (pt)
AP (1) AP2007004084A0 (pt)
AU (1) AU2005324199A1 (pt)
BR (1) BRPI0519606A2 (pt)
CA (1) CA2593563A1 (pt)
EA (1) EA200701434A1 (pt)
IL (1) IL184221A0 (pt)
MA (1) MA29238B1 (pt)
MX (1) MX2007008196A (pt)
NO (1) NO20074937A (pt)
TN (1) TNSN07226A1 (pt)
WO (1) WO2006072259A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX360827B (es) 2007-11-30 2018-11-16 Univ California Metodos para tratar la esteatohepatitis no alcoholica (nash) usando productos de cisteamina.
CN103382170B (zh) * 2012-10-25 2015-04-08 潜江永安药业股份有限公司 一种牛磺酸的制备方法
CN106728405A (zh) * 2016-11-15 2017-05-31 陈思文 一种牛磺酸和水溶性茶多酚复方组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58140017A (ja) * 1981-12-22 1983-08-19 Junichi Azuma 心不全治療剤
JPH08208464A (ja) * 1994-12-02 1996-08-13 Taisho Pharmaceut Co Ltd 高脂血症の治療及び予防薬
US6184227B1 (en) * 1995-07-21 2001-02-06 Savvipharm Inc. Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
SE9601395D0 (sv) * 1996-04-12 1996-04-12 Dieter Haeussinger New therapeutic treatment 1
GB9722361D0 (en) * 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders
NZ527924A (en) * 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
WO2001026642A2 (en) * 1999-10-08 2001-04-19 Joyce Corinne Bechthold Methods and compositions for treating neurobehavioral disorders
CN1340502A (zh) * 2000-06-30 2002-03-20 张永春 牛磺酸合锌的生产工艺
CN1268733C (zh) * 2004-07-20 2006-08-09 刘辉 牛磺酸功能啤酒及其生产工艺

Also Published As

Publication number Publication date
CA2593563A1 (en) 2006-07-13
AP2007004084A0 (en) 2007-08-31
MA29238B1 (fr) 2008-02-01
AU2005324199A1 (en) 2006-07-13
IL184221A0 (en) 2008-12-29
JP2008526789A (ja) 2008-07-24
TNSN07226A1 (en) 2008-11-21
EA200701434A1 (ru) 2008-10-30
NO20074937A (no) 2007-09-28
CN101146767A (zh) 2008-03-19
WO2006072259A2 (en) 2006-07-13
EP1844006A2 (en) 2007-10-17
KR20070091198A (ko) 2007-09-07
MX2007008196A (es) 2008-02-22
WO2006072259A3 (en) 2007-10-04

Similar Documents

Publication Publication Date Title
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
CY1118601T1 (el) Αλκυλαμινο-υποκατεστημενες δικυανοπυριδινες και προφαρμακα τυπου εστερα αμινοξεος αυτων
PE20060654A1 (es) Conjugados de hormona del crecimiento humana y politilenglicol ramificado con glicerol y proceso de preparacion
WO2008076270A3 (en) Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
BRPI1012141A2 (pt) conjugado de sirna e método de preparação do mesmo
BRPI0913580B8 (pt) compostos de pirrolopiridinas como inibidores de quinase e composição farmacêutica compreendendo os referidos compostos
EA200800100A1 (ru) Соединения азаиндазола и способы применения
EA200601353A1 (ru) Селективные модуляторы рецепторов эстрогена для лечения вазомоторных симптомов
BRPI0506970B8 (pt) derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior
WO2010091067A3 (en) Derivatives of [1, 3] oxazin- 2-one useful for the treatment of metabolic diseases such as lipid disorders
CY1112831T1 (el) Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh
EA201000210A1 (ru) Агонисты пиридон gpr119, сопряженного с g-белком рецептора
EA201171216A1 (ru) Фенилацетат l-орнитина и способы его получения
CY1112499T1 (el) Φαρμακευτικες συνθεσεις ενος νευροδραστικου στεροειδους και χρησεις αυτων
MX2010001881A (es) Derivados de piridina como moduladores del receptor s1p1/edg1.
WO2013016668A3 (en) Methylphenidate-prodrugs, processes of making and using the same
GT200600455A (es) Derivados de la 1-amino-ftalazina sustituida, su preparación y su aplicación en terapéutica
ATE485261T1 (de) Salicylsäurederivate
CY1111240T1 (el) Παραγωγα ετεροαρυλουριας χρησιμα για την αναστολη της chk1
EA200901572A1 (ru) 3-(имидазолил)пиразоло[3,4-b]пиридины
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
BRPI0519606A2 (pt) sÍntese, produÇço e utilidade da taurina como um remÉdio
CY1111128T1 (el) Στεροειδη παραγωγα 17-φωσφορου χρησιμα ως τροποποιητες υποδοχεων προγεστερονης
ECSP077306A (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparación y su uso como antiinflamatorios
WO2007118832A3 (en) Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 6A ANUIDADE.